CN118240804B

CN118240804B - Xylanase mutant and application thereof

Info

Publication number: CN118240804B
Application number: CN202410674577.4A
Authority: CN
Inventors: 徐雪梅; 黄庆华; 吴秀秀; 黄亦钧; 郭娇; 金融
Original assignee: Weifang Kdn Biotech Co ltd
Current assignee: Weifang Kdn Biotech Co ltd
Priority date: 2024-05-29
Filing date: 2024-05-29
Publication date: 2024-07-19
Anticipated expiration: 2044-05-29
Also published as: CN118240804A

Abstract

The invention relates to the technical fields of genetic engineering and protein engineering, and particularly provides a xylanase mutant and application thereof. The xylanase mutant comprises N128L and/or G212V mutation sites, and after being treated for 5min at 95 ℃, the enzyme activity residual rate is obviously higher than that of a wild type, and unexpected technical effects are achieved. The xylanase mutant provided by the invention has stronger heat resistance, is more suitable for being applied to the field of feed than a wild type, and has wide prospects.

Description

Xylanase mutant and application thereof

Technical Field

The invention relates to the technical fields of genetic engineering and protein engineering, in particular to a xylanase mutant and application thereof.

Background

Endo-xylanase (EC 3.2.1.8) randomly hydrolyzes beta-1, 4-xyloside bonds in xylan, thereby obtaining products such as xylo-oligosaccharides with different sizes; thereby disrupting the hemicellulose structure of the cell wall.

Most of feeds for livestock and poultry are plant feed raw materials, the cell walls of the plant feed raw materials contain non-starch polysaccharide components such as xylan, and particularly the xylan content in wheat feed raw materials such as wheat is relatively high. The non-starch polysaccharide substances such as xylan and the like can increase the viscosity of chyme in the digestive tract of livestock and poultry, reduce the contact of nutrient substances with endogenous enzymes such as protease, amylase and the like, reduce the utilization rate of feed, enable more nutrient substances to reach the rear intestines of the livestock and poultry to be utilized by harmful microorganisms, influence the health of the digestive tract of the livestock and poultry, and solve the problems of raw material excrement, diarrhea, anus pasting and the like.

The external source is added with xylanase to degrade xylan and generate xylo-oligosaccharide such as xylobiose, xylotriose and the like, on one hand, the viscosity of chyme in the digestive tract of livestock and poultry can be reduced, the utilization rate of feed is improved, on the other hand, the generated xylo-oligosaccharide can be used as a prebiotic to promote the reproduction of beneficial intestinal bacteria, improve the intestinal environment of livestock and poultry, and solve the problems of excrement, diarrhea, anus pasting and the like of livestock and poultry. Therefore, xylanase is commonly added into the feed, so that the digestibility of the feed is improved, the production performance of livestock and poultry is improved, and the feed cost is reduced.

The GH11 family xylanases have higher specific activities, but poor temperature resistance. In the feed production process, high temperature pelletization (80-85 ℃) is extremely easy to cause xylanase inactivation. Improving the temperature resistance of the enzyme through directed evolution and semi-rational design transformation is an important means for solving the problem.

Disclosure of Invention

The invention aims to solve the problems in the prior art, and protein engineering is performed on xylanase from rumen anaerobic fungi (Neocallimastix frontalis), and a high-temperature resistant xylanase mutant is obtained by screening. The mutant can be widely applied to the field of feed processing.

One aspect of the invention relates to a xylanase mutant, which is characterized in that the 128 th amino acid of xylanase with an amino acid sequence of SEQ ID NO. 2 is mutated from Asn to Leu.

In one aspect, the invention relates to a xylanase mutant, which is characterized in that the 128 th amino acid of xylanase with an amino acid sequence of SEQ ID NO. 2 is mutated from Asn to Leu, and the 212 nd amino acid is mutated from Gly to Val.

The amino acid sequence of the xylanase mutant is SEQ ID NO. 5 or SEQ ID NO. 7.

The invention also relates to DNA molecules encoding the xylanase mutants.

The invention also relates to recombinant expression plasmids containing the DNA molecules.

The invention also relates to a host cell comprising the recombinant expression plasmid.

The heat resistance of the recombinant xylanase mutant is obviously improved by transferring the plasmid into a host cell.

In some embodiments of the invention, the host cell is Pichia pastoris (Pichia pastoris).

The invention provides xylanase mutants respectively containing N128L, G V single mutation sites on the basis of wild xylanase PT, and the enzyme activity residual rate is respectively improved by 21.5 percent and 16.4 percent after the xylanase mutants are treated for 5 minutes at the temperature of 95 ℃; after the mutant containing the combination of the N128L mutation sites and the G212V mutation sites is treated for 5min at the temperature of 95 ℃, the residual rate of the enzyme activity is up to 90.16%, the heat resistance is further enhanced compared with that of a single-point mutant, and unexpected technical effects are obtained. The xylanase mutant has stronger heat resistance, is more suitable for being applied to the field of feeds than a wild type, and has wide prospects.

Detailed Description

The invention discloses a xylanase mutant, a preparation method and application thereof, and DNA molecules, vectors and host cells for encoding the xylanase mutant, and the xylanase mutant can be realized by appropriately improving process parameters by a person skilled in the art by referring to the content of the text. While the methods and applications of this invention have been described in terms of preferred embodiments, it will be apparent to those skilled in the relevant art that variations and modifications can be made in the methods and applications described herein, and in the practice and application of the techniques of this invention, without departing from the spirit or scope of the invention.

The present invention uses conventional techniques and methods used in the fields of genetic engineering and molecular biology, such as MOLEC μm LAR CLONING: a LABORATORY MANUAL,3nd Ed. (Sambrook, 2001) and CURRENT PROTOCOLS IN MOLEC μm LAR BIOLOGY (Ausubel, 2003). These general references provide definitions and methods known to those skilled in the art. However, those skilled in the art may adopt other methods, experimental schemes and reagents which are conventional in the art on the basis of the technical scheme described in the present invention, and are not limited to the specific embodiments of the present invention. For example, the invention may be used with the following experimental materials and reagents:

Strains and vectors: coli DH 5. Alpha., pichia pastoris GS115, vector pPIC9k, amp, G418 were purchased from Invitrogen corporation.

Enzyme and kit: the PCR enzyme and the ligase were purchased from Takara, the restriction enzyme from Fermentas, the plasmid extraction kit and the gel purification recovery kit from Omega, and the GeneMorph II random mutagenesis kit from Beijing Bomeis Biotechnology Co.

The formula of the culture medium comprises:

Coli medium (LB medium): 0.5% yeast extract, 1% peptone, 1% NaCl, pH7.0;

yeast Medium (YPD Medium): 1% yeast extract, 2% peptone, 2% glucose;

Yeast screening medium (MD medium): 2% peptone, 2% agarose;

BMGY medium: 2% peptone, 1% yeast extract, 100 mM potassium phosphate buffer (pH 6.0), 1.34% YNB, 4X 10 ^-5% biotin, 1% glycerol;

BMMY medium: 2% peptone, 1% yeast extract, 100 mM% potassium phosphate buffer (pH 6.0), 1.34% YNB, 4X 10 ^-5% biotin, 0.5% methanol;

LB-AMP medium: 0.5% yeast extract, 1% peptone, 1% NaCl, 100. Mu.g/mL ampicillin, pH7.0;

LB-AMP plate: 0.5% yeast extract, 1% peptone, 1% NaCl,1.5% agar, 100. Mu.g/mL ampicillin, pH7.0;

the invention is further illustrated by the following examples.

EXAMPLE 1 construction of recombinant plasmid

Xylanase genes from rumen anaerobic fungi (Neocallimastix frontalis) were optimized according to pichia codon preference. The optimized nucleotide sequence is synthesized by Shanghai JieRui bioengineering Co. The xylanase gene is named PT, and the nucleotide sequence of the xylanase gene is SEQ ID NO:1, the encoded amino acid sequence is SEQ ID NO:2.

The xylanase gene was digested with restriction enzymes EcoR I and Not I (Fermentas); at the same time, plasmid pPIC9K was digested with restriction enzymes EcoR I and Not I. The cleavage products were purified using a gel purification kit and the two cleavage products were ligated with T4 DNA ligase (Fermentas). The ligation product was transformed into DH 5. Alpha. E.coli (Invitrogen) and selected with ampicillin. To ensure accuracy, several clones were sequenced (Sangon).

The plasmid was purified from E.coli clones with correct sequencing results using a plasmid miniprep kit (Omega) to obtain 1 recombinant plasmid, which was designated pPIC9K-PT.

EXAMPLE 2 selection of high temperature resistant mutants

In order to further increase the thermostability of xylanase PT, the applicant performed protein structure analysis on it. The protein is GHI1 family xylanase, and the structure of the protein is beta-jelly roll structure. Applicants have performed a number of mutated screens for this enzyme by directed evolution techniques.

1.1 Design of PCR primers PT-F1, PT-R1:

PT-F1: GGCGAATTCCAAAGTTTCTGTAGTTCAGCTTCTC (SEQ ID NO:3, underlined is the restriction endonuclease EcoRI recognition site);

PT-R1: ATAGGCGGCCGCTTAATCACCAATGTAAACCTTTG (SEQ ID NO:4, underlined is the restriction endonuclease NotI recognition site).

The PT gene (SEQ ID NO: 1) is used as a template, the primers are used for carrying out PCR amplification by using a GeneMorph II random mutation PCR kit (Bomeis), PCR products are recovered by glue, ecoRI and NotI are subjected to enzyme digestion treatment and then are connected with pET21a carriers subjected to enzyme digestion, the products are transformed into escherichia coli BL21 (DE 3), the escherichia coli BL21 are coated on LB+Amp plates, inverted culture is carried out at 37 ℃, after the transformants appear, the transformants are picked up to 96-well plates one by using toothpicks, 150 mu l of LB+Amp culture medium containing 0.1mM IPTG is added into each well, about 6 h is cultivated at 37 ℃, supernatant is centrifugally discarded, and bacterial cells are resuspended by buffer solution and repeatedly frozen and broken to obtain escherichia coli cell lysate containing xylanase.

And respectively taking out 30 uL lysate to two new 96-well plates, wherein one 96-well plate is treated at 95 ℃ for 5 min, 30 uL substrates are added to the two 96-well plates, after 30 min of reaction is carried out at 37 ℃, the generated reducing sugar is measured by a DNS method, and the activities of different mutants are different after high-temperature treatment. Experimental results show that some mutations have no effect on the heat resistance of xylanase, and some mutations even make the heat resistance or enzyme activity worse; in addition, some mutations, although improving the temperature tolerance of xylanase, have significantly changed enzymatic properties after mutation, which are all undesirable. Finally, the mutation site which can remarkably improve the heat resistance of xylanase and does not influence the enzyme activity and the original enzymatic property of xylanase is obtained: N128L, G212V.

Based on the wild xylanase PT, the invention provides mutants containing single mutation sites of N128L and G212V and combination of the two mutation sites, and the amino acid sequences of the mutants are SEQ ID NO. 5, SEQ ID NO. 6 and SEQ ID NO. 7 respectively.

EXAMPLE 3 xylanase expression in Pichia pastoris

3.1 Construction of expression vectors

The gene sequences of xylanase PT and its mutant are optimized according to the cipher preference of Pichia pastoris, and synthesized by Shanghai Jierui biological engineering Co., ltd, and EcoRI and NotI cleavage sites are added at the 5 'and 3' ends of the synthesized sequence.

The gene sequences of the synthesized xylanase PT and its mutants were digested with EcoRI and NotI, respectively, and then ligated overnight at 16℃with the pPIC-9K vector digested in the same manner, and transformed into E.coli DH5a, which was spread on LB+Amp plates, cultured upside down at 37℃and subjected to colony PCR (reaction system: template-picked monoclonal, rTaqDNA polymerase 0.5. Mu.l, 10 XBuffer 2.0. Mu.l, dNTPs (2.5 mM) 2.0. Mu.l, 5'AOX primer (10 mM): 0.5. Mu.L, 3' AOX primer: 0.5. Mu.L, ddH ₂ O14.5. Mu.L, reaction procedure: 5min pre-denatured at 95℃30 cycles: 94℃30sec,55℃30sec,72℃2min,72℃10 min) after the appearance of the transformants. And (3) verifying positive clones, and obtaining the correct recombinant expression plasmid after sequencing verification.

3.2 Construction of Pichia pastoris engineering strains

3.2.1 Yeast competent preparation

Performing YPD plate activation on Pichia pastoris GS115 strain, culturing at 30 ℃ for 48 h, inoculating activated GS115 monoclonal in a 6 mL YPD liquid culture medium, culturing at 30 ℃ for 220 rpm, transferring bacterial liquid after culturing at about 12h into a triangular flask filled with 30mL of YPD liquid culture medium, culturing at 30 ℃ for about 5 hours at 220 rpm, detecting the bacterial density by an ultraviolet spectrophotometer, respectively collecting 4mL of bacterial bodies after OD600 value is in the range of 1.1-1.3, centrifuging at 4 ℃ 9000 rpm for 2 min into a sterilized EP tube, slightly discarding supernatant, sucking residual supernatant with sterilized filter paper, re-suspending the bacterial bodies with precooled 1mL sterilized water, centrifuging at 4 ℃ 9000 rpm for 2 min, slightly discarding supernatant, re-washing with 1mL sterilized water once, centrifuging at 4 ℃ 9000 rpm for 2 min, slightly discarding supernatant, and re-suspending the pre-cooled 1mL sorbitol (1 mol/L); centrifuge 2 min at 4℃with 9000 rpm, gently discard supernatant, gently resuspend cells with 100-150. Mu.l sorbitol (1 mol/L) pre-chilled.

3.2.2 Transformation and screening

Linearizing the recombinant expression plasmid obtained by constructing 3.1 by Sac I, purifying and recovering linearization fragments, respectively converting Pichia pastoris GS115 by electroporation, screening on an MD plate to obtain Pichia pastoris recombinant strain, and screening multiple copies of transformants on YPD plates (0.5 mg/mL-8 mg/mL) containing geneticin at different concentrations.

Transferring the obtained transformants into BMGY culture medium respectively, and culturing at 30 ℃ and 250rpm in a shaking way for 1d; then transferring the strain into a BMMY culture medium, and carrying out shaking culture at 30 ℃ and 250 rpm; adding 0.5% methanol every day, and inducing expression 4 d; and (3) centrifuging at 9000rpm for 10min to remove thalli, thus obtaining fermentation supernatant respectively containing xylanase PT and xylanase mutants.

3.3 Xylanase enzyme Activity assay

(1) Definition of xylanase activity units

The amount of enzyme required to release 1. Mu. Mol of reducing sugar per minute from a xylan solution having a concentration of 5mg/ml at 37℃and pH 5.5 is one enzyme activity unit U.

(2) Enzyme activity determination method

Taking a xylan substrate (prepared by pH5.5 acetic acid-sodium acetate buffer solution) with the concentration of 2 ml being 1%, adding the xylan substrate into a colorimetric tube, balancing 10min at 37 ℃, adding 2 ml, properly diluting by pH5.5 acetic acid-sodium acetate buffer solution, mixing the xylanase enzyme solution with the balanced acidic xylanase enzyme solution at 37 ℃, and carrying out accurate heat preservation reaction at 37 ℃ for 30 min. After the reaction was completed, 5 ml DNS reagents were added and mixed well to terminate the reaction. Boiling in boiling water bath for 5 min deg.C, cooling to room temperature with tap water, adding distilled water to constant volume of 25: 25 ml, mixing, and measuring absorbance A _E at 540 and nm with standard blank as blank.

Enzyme activity calculation formula:

X_D=[(A_E-A_B)×K+ C₀] ×N×1000/(M×t)。

Wherein: x _D is the activity of xylanase in the diluted enzyme solution, U/mL; a _E is absorbance of enzyme reaction solution; a _B is absorbance of enzyme blank solution; k is the slope of the standard curve; c ₀ is the intercept of the standard curve; m is the molar mass of xylose, 150.2 g/mol; t is enzymolysis reaction time, min; n is the dilution multiple of the enzyme solution; 1000 is the conversion factor, 1mmol = 1000 μmol.

(3) Enzyme activity measurement results

The enzyme activity detection is carried out according to the method, and the result shows that: the enzyme activity of the recombinant strain fermentation supernatant of the recombinant expression xylanase PT and the mutant thereof is 300-600U/mL.

EXAMPLE 4 Heat resistance analysis of xylanase mutants

And respectively diluting the recombinant strain fermentation supernatant of the recombinant expression xylanase PT and the recombinant expression xylanase mutant obtained by constructing to about 20U/mL by using acetic acid-sodium acetate buffer solution with pH of 5.5, treating the recombinant strain fermentation supernatant at 95 ℃ for 5min, measuring the residual enzyme activity, and calculating the enzyme activity residual rate by taking the enzyme activity of an untreated sample as 100%. The specific results are shown in Table 1.

TABLE 1 Heat resistance analysis of xylanase mutants

Xylanase mutants	Residual rate of enzyme activity after 5min of treatment at 95 DEG C
		PT	70.00%
N128L	85.05%
		G212V	81.48%
N128L/G212V	90.16%

As can be seen from the results in Table 1, the xylanase mutants containing single mutation sites of N128L, G V respectively showed an improvement in enzyme activity residual rate of 21.5% and 16.4% respectively after 5min treatment at 95℃as compared with the wild-type xylanase PT; and after the mutant containing the combination of the N128L mutation sites and the G212V mutation sites is treated for 5min at the temperature of 95 ℃, the residual rate of the enzyme activity is up to 90.16%, the heat resistance is further enhanced compared with that of the single-point mutant, and unexpected technical effects are obtained.

In conclusion, the xylanase mutant provided by the invention has stronger heat resistance, is more suitable for being applied to the field of feeds than a wild type, and has a broad prospect.

Claims

1. A xylanase mutant, which is characterized in that the mutant is characterized in that the 128 th amino acid of xylanase with an amino acid sequence of SEQ ID NO. 2 is mutated from Asn to Leu.

2. A xylanase mutant, characterized in that the mutant is characterized in that amino acid 212 of the xylanase mutant of claim 1 is mutated from Gly to Val.

3. A DNA molecule encoding the xylanase mutant of claim 1 or 2.

4. A recombinant expression plasmid comprising the DNA molecule of claim 3.

5. A host cell comprising the recombinant expression plasmid of claim 4; the host cell is Pichia pastoris.